CRP and Posterior Leukoencephalopathy Syndrome: All patients had complete available medical data records on demographic variables, clinical (symptoms and blood pressure values at onset of PRES) and laboratory data (creatinine, C-reactive protein, coagulation status), brain MR imaging as well as duration of hospital stay except of 3 patients whose exact blood pressure levels at initial PRES toxicity were unknown.